NRSN - NeuroSense Therapeutics, Ltd. PEG multiplikatori
NeuroSense Therapeutics (NRSN) dori vositalarini bozorga chiqarish muddatini qisqartirish uchun biomarkerlar tahlilida avtomatlashtirishni joriy qilmoqda. Kimyoviy komponentlar uchun uzluksiz logistika tadqiqot jadvaliga qat'iy rioya qilinishini ta'minlaydi. O'sish istiqbollari PrimeC dorisi va potentsial birlashuvlar bilan bog'liq. Baholash va o'sish muvozanati ko'rsatkichi aktivning qiymat dinamikasini aks ettiradi, bunda 0.00 ushbu metrikaning joriy darajasidir.
NeuroSense Therapeutics (NRSN) kompaniyasining tahliliy kesimlari
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi statistikasi:
- balans bo'yicha xususiy kapital ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati koeffitsiyenti NeuroSense Therapeutics|NRSN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati neurosense-tx.com|NRSN - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati NeuroSense Therapeutics, Ltd.|NRSN - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi NeuroSense Therapeutics|Shoshilinch likvidlik neurosense-tx.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
NRSN - Sof daromad|Kutilayotgan sof daromad NeuroSense Therapeutics|NRSN - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati neurosense-tx.com|NRSN - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati NeuroSense Therapeutics, Ltd.|NRSN - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda NeuroSense Therapeutics|NRSN - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi neurosense-tx.com|NRSN - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi NeuroSense Therapeutics
Kompaniyaning fundamental tahlili:NeuroSense Therapeutics Ltd (NRSN)
NeuroSense Therapeutics (NRSN) himoyalangan patent portfeli tufayli ALS terapiyasi sohasida mustahkam pozitsiyani saqlab qolmoqda. peg_co koeffitsiyenti tahlili joriy P/E koeffitsiyentini biznesning kengayish sur'atlari bilan solishtirish imkonini beradi. Ushbu ko'rsatkich aksiya narxi foydadan sekinroq o'sgan taqdirda, aktivning qadrini past baholanganini ko'rsatadi. Grant moliyalashtirilgan biotexnologiya kompaniyasi uchun bu R&D xarajatlarining samaradorligini tasdiqlaydi. Birga solishtirganda pastroq qiymat an'anaviy ravishda fundamental jihatdan istiqbolli kompaniyalar uchun sotib olish signaliga hisoblanadi.
NeuroSense Therapeutics raqobatchilari
BIIB - O‘sish sur’atiga tuzatilgan narx-foyda|Neurocrine Biosciences Inc - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Regencell Corp RGC|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACAD (acadia-pharm.com)|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Viking Therapeutics Inc (VKTX)|Narxning foydaga va o‘sish sur’atiga nisbati Supernus Pharma|Catalyst Corp (CPRX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori DNLI|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven BHVN|AMLX: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|TRVI - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Praxis Corp PRAX|AVXL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda ceribell.com (CBLL)|Narx-foyda va o‘sish multiplikatori PRTA|ALEC: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori ANNX (Annexon Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati OMER|PEG multiplikatori NGNE (Neurogene Inc.)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACIU|Voyager Therapeutics, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Neumora|Scilex Holding Co. (SCLX) - Narxning foydaga va o‘sish sur’atiga nisbati|Tevogen Bio Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|ACOG (Alpha Cognition Inc) - PEG multiplikatori|PEG multiplikatori cogrx.com|Narxning foydaga va o‘sish sur’atiga nisbati Inhibikase Therapeutics, Inc. (IKT)|SAVA: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ASRT (Assertio)|Coya Therapeutics Inc (COYA) - O‘sish sur’atiga tuzatilgan narx-foyda|VTGN: Narx-foyda va o‘sish multiplikatori|OVID - PEG multiplikatori|ABOS (Acumen Pharmaceuticals, Inc.) - Narx-foyda va o‘sish multiplikatori|CRVO: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ATHE (Alterity Therapeutics Ltd.) - PEG multiplikatori|Clene Nanomedicine (CLNN) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori PEPG|Narx-foyda va o‘sish multiplikatori jupiterneurosciences.com JUNS|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Therapeutics, Inc. RLMD|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Annovis Bio Inc (ANVS)|GRCE - Narxning foydaga va o‘sish sur’atiga nisbati|AIFF (Firefly Neuro) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|anewmeds.com (KLTO) - Narxning foydaga va o‘sish sur’atiga nisbati|revivapharma.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati MetaVia Inc.|NeurAxis Inc. (NRXS) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Helius Medical (HSDT)|passagebio.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Neuphoria Therapeutics NEUP|NERV: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Athira Pharma - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Addex Therapeutics Ltd.|ALZN (alzamend.com) - Narx-foyda va o‘sish multiplikatori|Cyclerion Therapeutics, Inc. (CYCN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|KTTA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Cortigent, Inc. (CRGT)|ATXI - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|CARA: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Chromocell Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Eliem Therapeutics|ITCI (intracellulartherapies.com) - Narx-foyda va o‘sish multiplikatori|Longboard Pharmaceuticals Inc (LBPH) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Marinus|NKGN: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharmaceuticals (NRBO)|SAGE - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Synaptogenix SNPX|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Trevena Inc. (TRVN)|Vigil Neuro - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Anew Medical Inc.|Cerevel Therapeutics (CERE) - Narxning foydaga va o‘sish sur’atiga nisbati
